Font Size

- Aa +

Tue 12 Aug 2008 04:00 AM

Font Size

- Aa +

Molecular imaging centre for Tawam

Tawam Hospital was further boosted by announcement that work is underway on a state-of-the-art medical molecular imaging centre located in its campus.

Tawam Hospital was further boosted by announcement that work is underway on a state-of-the-art medical molecular imaging centre located in its campus.

An agreement between Mubadala Development Company and Siemens Healthcare last year signalled an intent to create a diagnostic imaging facility, but work officially began with a ground breaking ceremony last month.

Scheduled for completion in 2009, the Tawam Molecular Imaging Centre will reportedly offer revolutionary diagnostic imaging systems with an aim to improve the speed and accuracy of detecting and tracking cancer, cardiovascular and neurological diseases.

The centre will be kitted out with a PET/CT diagnostic system (a hybrid combining Positron Emission Tomography and Computed Tomography), which allows images to be produced with greater speed and will enable physicians to view both metabolic activity and pinpoint where abnormal lesions are located using the same image.

The centre will also feature a Siemens Cyclotron particle accelerator that produces high yields of reliable radioisotope biomarkers required for PET examinations.

Johns Hopkins Medicine International will act as the clinical operator of the facility.

His Excellency Dr. Ahmed Al Mazrouei, Chairman of Health Authority Abu Dhabi (HAAD), said: "The creation of the Tawam Molecular Imaging Centre is an excellent example of how the experience and expertise of international private healthcare providers can be brought together to create outstanding healthcare facilities for the region. It is also in line with HAAD's strategy to establish partnerships with the public and private sector to ensure excellent quality healthcare for the community."

For all the latest health tips & news from the UAE and Gulf countries, follow us on Twitter and Linkedin, like us on Facebook and subscribe to our YouTube page, which is updated daily.